Results 171 to 180 of about 309,789 (330)
Effects of Biological Sex and Age on Cerebrospinal Fluid Markers—A Retrospective Observational Study
ABSTRACT Objective Cerebrospinal fluid (CSF) analysis is a key diagnostic tool for neurological diseases. To date, only a few studies have investigated in larger cohorts the effect of age and biological sex on diagnostic markers extracted from CSF. Methods For this retrospective observational study, 4163 CSF findings (2012–2020) were evaluated.
Isabel‐Sophie Hafer +3 more
wiley +1 more source
Impact of patient programs on adherence and persistence in inflammatory and immunologic diseases: a meta-analysis. [PDF]
Burudpakdee C +4 more
europepmc +1 more source
Skin microdialysis detects distinct immunologic patterns in chronic inflammatory skin diseases [PDF]
Moritz M. Hollstein +12 more
openalex +1 more source
ABSTRACT Background SOX1 antibody‐positive paraneoplastic neurological syndromes (PNS) exhibit significant population‐specific clinical heterogeneity. While Western cohorts predominantly manifest Lambert‐Eaton myasthenic syndrome (65%–80%), comprehensive clinical characterization and treatment response data in Asian populations remain critically ...
Jin‐Long Ye +11 more
wiley +1 more source
Gingival status: An indicator of disease progression and its correlation with the immunologic profile in HIV-infected children on antiretroviral therapy [PDF]
J. P. Beena
openalex +1 more source
We report the national burden of dermatopolymyositis mortality over the past quarter century using the US national vital statistics data. Age‐standardized mortality rates for dermatopolymyositis decreased at an annual rate of 3.8% each year, which was higher than the annual percent decrease for deaths from all other causes.
Elizabeth Matz, Ram R. Singh
wiley +1 more source
Closed-loop medication safety management reduces inappropriate medication in elderly patients with rheumatic and immunologic diseases. [PDF]
Chen D, Feng J, Chen Z, Chen M.
europepmc +1 more source
Objective This study aimed to evaluate the impact of a series of policies that mandated switching patients with inflammatory arthritis (IA) from an originator biologic to a biosimilar in British Columbia, Canada, on health care resource use and cost.
HaoHung Dang +4 more
wiley +1 more source

